SafeTrace(R) and SafeTrace Tx(R)* Will Be Installed at Prominent Utah Reference Laboratory and Centralized Transfusion Service DENVER, Sept. 22 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of a contract with ARUP Laboratories for its SafeTrace(R) donor management system and SafeTrace Tx(R) advanced transfusion management system. ARUP Laboratories is a national reference laboratory owned by the University of Utah. ARUP will use SafeTrace and SafeTrace Tx to manage its blood donor center and centralized transfusion service. Terms of the contract were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Gloria Pitt, Assistant Vice President and IT Manager at ARUP, said, "We were in need of a software management system that could handle our current volume, as well as grow with us to meet projected needs to process more than 40,000 blood donations and more than 130,000 blood transfusion-related tests per year." Ms. Pitt continued, "We were comfortable that SafeTrace and SafeTrace Tx could handle our needs both now and in the future. In addition, the Centralized Transfusion Service functionality and proven HL7 Interfaces in SafeTrace Tx, as well as the Vein-to-Vein(R) link to SafeTrace, were important features which helped drive our decision to move forward with Wyndgate Technologies." Wm. Scott Dustin, Wyndgate's Vice President of Sales and Marketing, stated, "Robust functionality, interfaces to information systems, as well as analyzers, and stable software applications are critical for large and complex organizations such as ARUP Laboratories. Our SafeTrace and SafeTrace Tx products are recognized leaders in these areas and we are proud to add ARUP Laboratories to our growing customer base." About ARUP Laboratories ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and an enterprise of the University of Utah and its Department of Pathology. With nearly 1,800 employees, ARUP offers in excess of 2,000 tests and test combinations, ranging from routine screening tests to highly esoteric molecular and genetic assays, for patients throughout the country. Rather than competing with its clients for physician office business, ARUP chooses instead to support clients' existing test menus by offering highly complex and unique tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services. ARUP's clients include more than half of the nation's university teaching hospitals and children's hospitals, as well as multi-hospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology(TM). ARUP also operates a Blood Services division which is the sole blood provider to University of Utah Hospital, Huntsman Cancer Hospital, Primary Children's Medical Center, and Shriners Hospital for Children, representing approximately 25 percent of the blood transfused in Utah. Further information on ARUP Laboratories can be obtained at http://www.aruplab.com/. Contact Information: Ronald L. Weiss, M.D., M.B.A. - President and COO, (801) 584-5188 About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Saharan Africa. Together, the SafeTrace donor management system and the SafeTrace Tx advanced transfusion management system provide Vein-to-Vein tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. * Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies(R), Inc., +1-303-238-2000; or Investor Relations, John Nesbett, or Jordan Silverstein, both of The Investor Relations Group, +1-212-825-3210, for Global Med Technologies, Inc.; or Ronald L. Weiss, M.D., M.B.A., President and COO of ARUP Laboratories, +1-801-584-5188 Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web site: http://www.aruplab.com/ Web site: http://www.globalmedtech.com/

Copyright